1. Short title This Act may be cited as the Robin Danielson Menstrual Product and Intimate Care Product Safety Act of 2023 . 2. Findings The Congress finds as follows: (1) Menstrual products and intimate care products are widely used in the United States today, but there is not enough research on the safety of or potential chemical exposure from components of these products. (2) People who menstruate may be exposed to substances in tampons and other menstrual products for as long as 40 years over the course of their reproductive lives. The average person who menstruates may use up to 16,000 tampons in their lifetime. (3) Trace amounts of dioxins can be found in tampons and other menstrual products. The Environmental Protection Agency and the International Agency for Research on Cancer, an arm of the World Health Organization, have concluded that dioxins are a probable human carcinogen (cancer-causing agent). (4) Chemical testing of menstrual products from around the world have detected several additional chemicals of concern including phthalates, volatile organic compounds, pesticides, carbon disulfide, and per-and polyfluoroalkyl substances (PFAS). (5) Intimate care products frequently contain undisclosed fragrance chemicals, some of which may be allergens, reproductive toxins, and carcinogens. Such products also contain potentially harmful preservatives. Research released by Apothercare, Women’s Voices for the Earth, and Black Women for Wellness found that some intimate care products specifically inhibit the growth of lactobacillus, a crucial type of healthy bacteria found in the vaginal microbiome. Disruption of the vaginal microbiome can lead to significant health problems including bacterial vaginosis, increased risk of sexually transmitted diseases, and fertility concerns. (6) Intimate care products (especially douches and powders) have been associated with higher levels of toxic chemicals in the bodies of people who use them. Specifically, phthalate levels in urine were significantly higher in people who